Azclear

Quick links to important sections

Azclear

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azclear

Azclear: Definition and Composition

Property Description
Active ingredient Azelaic Acid (INN)
Form Topical Preparation (Cream, Lotion, Gel)
Pharmacological class Topical Antiacne Agent, Keratolytic Agent
Common use Promoting clearer, calmer skin appearance
Origin Derived (Synthesized dicarboxylic acid)

Azclear is a specific topical pharmaceutical product distinguished by its active ingredient, Azelaic Acid, a compound recognized as an International Nonproprietary Name (INN). This formulation is often marketed as an Over-The-Counter (OTC) option in its key regions, differentiating it from prescription-only retinoids. The active substance is a naturally occurring dicarboxylic acid that is typically synthesized for pharmaceutical use, though it is found in grains such as wheat and barley. The final preparation is generally presented as a Cream or Lotion, utilizing an emulsion-based vehicle that facilitates smooth application and optimal delivery across the skin layers.

What Type of Agent is Azelaic Acid and What is its Form?

Azelaic Acid is primarily classified within the pharmacological class of a Topical Antiacne Agent, and it is recognized to function concurrently as both a Keratolytic Agent and an Anti-inflammatory Agent. This combination reflects its ability to address multiple pathways involved in common skin appearances. Azelaic Acid possesses diverse physiological activities, including antibacterial and anti-keratinizing effects. These properties work to reduce inflammation and normalize skin cell processes without relying on classic antibiotic properties. The preparation is designated for topical use, reflecting its focused action on the epidermis.

What is the General Purpose of Azclear?

The general purpose of Azclear is to promote a clearer, calmer skin appearance by supporting the normalization of key skin processes, including cellular turnover. Its combination of actions—clearing the pores and reducing inflammation—supports the stabilization of skin texture and overall tone. Furthermore, Azelaic Acid reduces inflammatory mediators and reactive oxygen species, which contribute to oxidative damage. This helps to protect the skin from inflammation-related damage and discoloration. The overall benefit is achieving a more balanced skin environment.

What side effects are possible with Azclear?

Possible Side Effects and Safety Information

The regulatory safety profile for Azelaic Acid (Azclear) is characterized primarily by local application site reactions that are generally expected to occur early in treatment. This profile is defined by official frequency classifications found in documents such as the Summary of Product Characteristics (SmPC) and FDA labeling.

Frequency-Classified Adverse Reactions

The majority of documented effects relate to the skin and application area:

Classification Examples of Reactions
Very Common (ge1/10) Application site burning, pain, and pruritus (itching).
Common (ge1/100, <1/10) Application site erythema (redness), dryness, scaling, and tingling (paresthesia).
Uncommon (ge1/1,000, <1/100) Contact dermatitis, skin depigmentation, and application site swelling (oedema).

Safety Patterns and Serious Risks

The official labeling notes a time-related pattern: the common local reactions are typically observed during the first few weeks of treatment but generally subside with continued use.

Less frequently, adverse effects affecting other System Organ Classes have been reported. Rare, but clinically significant, systemic risks include hypersensitivity reactions of the Immune System, such as angioedema (swelling) and dyspnoea (shortness of breath), reported in post-marketing surveillance. The presence of these reactions establishes a contraindication against use in individuals with known sensitivity to the active ingredient or its components.

Population-Specific Safety Notes

The safety documentation includes specific monitoring requirements. Patients with a dark complexion are subject to monitoring for early signs of hypopigmentation (loss of skin color). Furthermore, the safety and efficacy of the 20% cream formulation have not been established in children younger than 12 years of age in the regulatory documents.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Azelaic Acid (Azclear) overdose is defined by both severe localized effects from overuse and potential life-threatening systemic reactions from hypersensitivity.

Documented Overdose Manifestations

Overuse of the topical product may result in severe or persistent local skin irritation, including increased pruritus, burning, stinging, or redness. Accidental contact with the product can lead to irritation of the eyes and other mucous membranes. The physiological systems documented as affected include the Integumentary System (severe irritation, swelling, hives) and the Respiratory System (dyspnea, or trouble breathing, and the worsening of asthma).

Required Emergency Actions

The most critical regulatory instruction is the response to life-threatening systemic hypersensitivity reactions. Immediate medical care must be sought for symptoms such as facial swelling, eye swelling, or difficulty breathing. Individuals are instructed to contact emergency services if symptoms are perceived as life-threatening.

If accidental contact with the eyes occurs, the area must be washed immediately with large amounts of water. A physician must be consulted if eye irritation persists after this procedure. Treatment must also be discontinued if persistent sensitivity or severe irritation develops. The labeling further states that patients with a dark complexion should be monitored for early signs of hypopigmentation.

Therapeutic Uses of Azclear

Main Uses and Benefits of Azclear

Azclear is a topical treatment primarily utilized for managing common inflammatory skin conditions. Its therapeutic effects are derived from its active ingredient, azelaic acid, which targets several underlying factors of skin congestion and irritation.

Primary Indications

  • Acne Vulgaris: Azclear is frequently used to treat mild to moderate acne. It works by reducing the growth of bacteria in the hair follicles and helping to clear the pores of cellular debris that can lead to comedones (blackheads and whiteheads).
  • Rosacea: The formulation is also indicated for the management of papulopustular rosacea. It helps to decrease the visible redness and the frequency of inflammatory lesions, such as bumps and pimples, associated with this chronic condition.

Key Therapeutic Benefits

  • Antibacterial Properties: The treatment exhibits antimicrobial activity against Cutibacterium acnes, the bacteria often associated with acne breakouts.
  • Keratolytic Action: Azclear assists in normalizing the keratinization process. By discouraging the buildup of dead skin cells, it helps prevent the formation of new blockages within the pores.
  • Anti-inflammatory Effects: The active ingredient possesses antioxidant properties that help neutralize free radicals and reduce the inflammatory response in the skin, which can alleviate swelling and redness.
  • Management of Hyperpigmentation: Azelaic acid is known to inhibit the activity of abnormal melanocytes. This can be beneficial in addressing post-inflammatory hyperpigmentation, helping to even out skin tone after acne lesions have healed.

Regulatory References

  1. NIH MedlinePlus overview of Azelaic Acid

Eligibility and Restrictions for Use

The eligibility for using Azclear (Azelaic Acid) is defined by official government labeling, focusing on age restrictions, known allergies, and specific health statuses. Use is contraindicated for any individual with a known hypersensitivity to azelaic acid or any other ingredient in the formulation.


Age-Specific Eligibility

Age Group Condition Regulatory Status
Children under 12 Acne Vulgaris Safety and efficacy have not been established.
Patients under 18 Papulopustular Rosacea Safety and efficacy have not been established.
Older Adults All uses Appropriate studies have not demonstrated geriatric-specific problems.

Conditional Use and Restrictions

Certain populations require caution as explicitly stated in the prescribing information:

  • Patients with Asthma: Use must be with caution due to postmarketing reports of asthma exacerbation.
  • Pregnancy: Use is advised only if clearly needed and when the potential benefit justifies the potential risk, due to low systemic absorption.
  • Lactation: Caution should be exercised; the infant must not come into direct contact with the treated skin/breast area.
  • Dark Complexions: Patients should be monitored for early signs of hypopigmentation (skin lightening), as data in this population is limited.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Azclear (Azelaic Acid) is defined by its method of use and minimal systemic exposure. Because it is applied topically and is absorbed into the bloodstream only minimally, regulatory authorities have concluded that no formal studies of systemic drug interactions with other medicinal products have been conducted. This classification means that the product's official labeling does not specify any contraindicated systemic combinations or pharmacokinetic interactions, such as those mediated by CYP enzymes or drug transporters.

Documented Interaction-Related Restrictions

Interaction Type Documented Constraint
Topical Pharmacodynamic Co-administration with other topical products that cause additive skin irritation is restricted. This includes products like peeling agents, abrasive cleansers, or astringents to prevent enhanced local effects.
Ingestible Substances Avoidance of alcoholic beverages, spicy foods, and thermally hot foods or drinks is advised, particularly for patients using the medicine for rosacea. This restriction is documented to prevent known disease-specific triggers from provoking flushing, redness, or blushing during treatment.

Official regulatory documents contain no mandated timing separation rules for administering Azelaic Acid with other medications, and no population-specific notes regarding interaction severity in populations with hepatic or renal impairment are stated. The interaction profile is solely based on local effects and disease-specific management constraints.

Mechanism of Action

Normalization of the Follicular Cell Cycle

This mechanism affects the process of follicular hyperkeratinization, the physical event preceding lesion development. Azelaic Acid acts as a cytostatic inhibitor of hyperproliferative keratinocytes, the cells lining the hair follicle. By interfering with the abnormal growth and differentiation of these cells, the molecule promotes the normalization of the epithelial cell turnover rate. This action restricts the excessive buildup of keratin and sebum, thereby mitigating the process of follicular obstruction.

Restricting the Viability of extitC. acnes Bacteria

The drug targets the growth and metabolism of the extitCutibacterium acnes ( extitC. acnes) population within the follicle. Azelaic Acid acts as a bacteriostatic agent by interfering with the bacteria's mitochondrial respiration and protein synthesis. This reduction in the microbial load reduces the release of bacterial metabolic byproducts and irritants into the surrounding tissue, which modulates the microbial contribution to inflammation.

Modulating Localized Oxidative and Immune Responses

Azelaic Acid functions as a modulator of the inflammatory cascade. It acts as a free radical scavenger, reducing Reactive Oxygen Species (ROS), and down-regulates key inflammatory mediators like Toll-like Receptor 2 (TLR2). This action suppresses the local immune and vascular signaling. The result is the physiological attenuation of localized tissue inflammation and its associated vascular responses.

Dosage and Administration Information

How Azclear (Azelaic Acid) is Used in Practice

Azelaic acid, the active ingredient in Azclear, is used according to established clinical practices that define the administration route, standard dosing, and application context. These principles ensure consistent use across various dermatological applications.

Administration Route and Formulations

This medicine is designed for topical administration only, applied directly to the affected skin area. The product is not intended for oral, ophthalmic, or intravaginal use. Commonly utilized dosage forms and strengths include a 20% Cream and a 15% Gel or Foam.

Standard Dosing and Frequency

The standard regimen involves applying a thin layer of the specific formulation to the affected areas twice daily, once in the morning and once in the evening. This frequency is a standard approach for the primary adult indications.

Use Patterns and Application Protocol

Use requires consistent application to skin that has been thoroughly cleansed with a mild product and patted dry beforehand. The product is gently but thoroughly massaged into the affected area, and hands should be washed immediately following application. Cosmetics may be applied once the azelaic acid preparation has dried. For rosacea, continuous therapy is typically followed, with a general timeframe for reassessment if no improvement is observed after 12 weeks of continuous use. If skin irritation occurs, the application frequency may be temporarily reduced to once daily or interrupted for a few days.

Population-Specific Use

For acne vulgaris in adolescents between 12 and 18 years of age, dose adjustment from the standard adult regimen is not required.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azclear (Azelaic Acid)


Evidence for use in Mild-to-Moderate Acne Vulgaris

The research base for Azelaic Acid's research explored for acne vulgaris includes many Randomized Controlled Trials (RCTs) and systematic reviews that summarize findings from those trials. These studies primarily focused on adolescents and adults dealing with mild-to-moderate forms of acne, where they measured changes in lesion counts, specifically inflammatory lesions and non-inflammatory lesions. Research examined short-term symptom changes, with most core trials monitoring outcomes over a period of about 12 weeks.

Studies report how symptoms evolved in the observed populations, and research examined patterns observed in the studies when the active ingredient was compared to an inactive vehicle (placebo) and other topical treatments used in the research. While the research base is large for typical cases, there are key limitations. Data for certain groups remain insufficient, meaning there is limited information regarding the research explored for its role as a single agent in more severe, nodular, or cystic acne.


Evidence for use in Papulopustular Rosacea

The research for Azelaic Acid in the context of rosacea has been evaluated in multiple studies, focusing on adults with the papulopustular form of the condition. Studies typically employed double-blind, vehicle-controlled RCTs to monitor changes related to inflammatory and irritative states. Researchers mainly monitored outcomes linked to inflammatory or irritative states, such as the change in the number of papules and pustules, and measured changes in overall facial redness (erythema) severity.

Findings describe patterns observed in the studies related to symptom intensity or variability over a typical period of 12 weeks. The research is largely focused on the papulopustular lesions, which are only one component of rosacea. Limited information is available from controlled trials specifically on the persistent fixed background redness that can be associated with rosacea. Furthermore, long-term effects are not fully established, as follow-up durations were limited in key efficacy trials.


Gaps in Research and Areas of Uncertainty

The research landscape provides context regarding group patterns, and evidence highlights what is known—and what is still uncertain. Comparative evidence is lacking in some areas, particularly against the newest generation of topical medications available today. Additionally, subgroup findings are uncertain for many specialized populations. While research provides insight into short-term changes, there is limited information for long-term outcomes and data characterizing long-term maintenance after the initial trial phase are not fully established across all indications. Finally, results apply only to the populations studied, meaning findings describe group patterns, not personal outcomes.

Key Studies & References NIH MedlinePlus overview of Azelaic Acid

Frequently Asked Questions (FAQ)

Common questions about Azclear (FAQ)

Q: What is the difference between Azclear and other azelaic acid products?

A: Azelaic acid preparations are available in different concentrations and forms, such as 20% cream and 15% gel or foam. According to official product information, these differing formulations have been studied and approved by regulatory bodies for use in specific skin conditions, such as acne vulgaris or papulopustular rosacea.


Q: Is the formula (lotion, cream, gel) important when choosing Azclear?

A: Yes, regulatory approvals link specific formulations to specific uses. Official documents indicate that different concentrations (like 20% or 15%) in cream, gel, or foam forms are used for different specific conditions, such as acne vulgaris or the inflammatory lesions of rosacea.


Q: Is Azclear designed to be used as a spot treatment or an all-over treatment?

A: Regulatory guidance specifies applying the medication topically and directly to the affected area where lesions are present. This description aligns with applying the product broadly across the affected skin area, as opposed to targeting only single, isolated lesions.


Q: What is the general purpose of Azclear?

A: The general purpose of azelaic acid, the active ingredient in Azclear, is defined by its approved uses. Official regulatory indications include the topical treatment of mild-to-moderate acne vulgaris and the inflammatory papules and pustules of mild-to-moderate rosacea.


Q: Is Azclear used for acne only, or does it treat other skin conditions?

A: Official regulatory indications for azelaic acid are limited to the treatment of acne vulgaris and papulopustular rosacea. The drug’s uses are based on the specific conditions for which research evidence has been evaluated by regulatory bodies.


Q: What is the difference in how Azclear treats blackheads vs. whiteheads?

A: Azelaic acid's mechanism of action addresses multiple factors in acne. Regulatory documents describe that it affects the abnormal cell turnover that causes pore obstruction (related to blackheads and whiteheads) and also restricts the growth of C. acnes bacteria, which contributes to inflammation.


Q: Why do official documents state Azclear is for 'mild to moderate' conditions?

A: Official documents state the approved uses are for mild-to-moderate conditions because the clinical trials that secured regulatory approval focused on and studied only those specific severities. The regulatory evidence base is derived specifically from studies focused on this severity level of the condition.


Q: Is the primary mechanism of Azclear related to exfoliation or anti-bacterial effects?

A: Regulatory documents describe azelaic acid as having a multifaceted mechanism of action. This includes both normalization of follicular cell turnover (a keratolytic action, similar to exfoliation) and restriction of C. acnes bacteria (a bacteriostatic action), alongside anti-inflammatory effects.


Q: How does the safety profile of Azclear relate to individuals who experience sensitive skin?

A: The regulatory safety profile indicates that local application site reactions such as burning, itching, and dryness are classified as very common. These effects typically occur early in treatment and may require temporary reduction in application frequency if they become severe.


Q: Does Azclear make the skin more sensitive to the sun?

A: Official documents generally advise avoiding excessive sun exposure, sun lamps, and tanning beds during treatment. This caution is common with many topical skin treatments.


Q: Are there any long-term side effects associated with Azclear use?

A: Regulatory data classify all known side effects based on frequency from clinical trials and post-marketing surveillance. However, research summaries indicate that there is limited long-term outcome data characterizing long-term maintenance after the initial key efficacy trials.


Q: Is the redness caused by Azclear temporary?

A: Official labeling notes a time-related pattern for common local reactions. Reactions like application site redness (erythema) are typically observed during the first few weeks of treatment but generally subside with continued use as the skin adjusts.


Q: Does Azclear contain any known allergens or irritants?

A: Official eligibility documents state that use is contraindicated for any individual with a known hypersensitivity to azelaic acid or any other ingredient in the formulation. The product's use is contraindicated for known hypersensitivity to any of its components, which includes all non-active ingredients in the formulation.


Q: How long does it typically take for skin tolerance to Azclear to improve?

A: Local application site reactions are typically observed during the first few weeks of treatment. Official documentation notes that these reactions generally subside with continued use, suggesting that local tolerance may develop as use continues.


Q: What is the role of Azclear in managing redness associated with breakouts?

A: Azelaic acid is described in official documents as a modulator of the inflammatory cascade. It works to reduce inflammatory mediators and suppress local vascular signaling, which physiologically attenuates tissue inflammation and the associated redness.


Q: Can Azclear be used during pregnancy or while breastfeeding?

A: Official documentation indicates that use during pregnancy is advised only if clearly needed and when the potential benefit is considered to justify the potential risk. During lactation, caution should be exercised, and the infant must not come into direct contact with the treated skin area, particularly the breast.


Q: Is Azclear known to interact with any common oral antibiotics?

A: Official regulatory labeling states that due to minimal systemic absorption, no formal studies of systemic drug interactions have been conducted, and no contraindicated systemic combinations are specified. This includes combinations with oral antibiotics.


Q: Are there any common foods or supplements that interact with Azclear?

A: The official interaction profile advises that patients using the medicine for rosacea should avoid known disease-specific triggers. These include alcoholic beverages, spicy foods, and thermally hot foods or drinks to prevent provocation of flushing or blushing during treatment.


Q: Can men and women use Azclear exactly the same way?

A: Official regulatory documentation does not note any difference in administration, dosing, or use patterns based on gender.


Q: Does Azclear interfere with hormonal birth control pills?

A: Official regulatory labeling states that due to minimal systemic absorption, no formal studies of systemic drug interactions, including those with hormonal birth control pills, have been conducted, and no systemic contraindications are specified.


Q: What do official safety documents indicate about use across different skin tones?

A: Official safety documentation includes a note that patients with a dark complexion are subject to monitoring for early signs of hypopigmentation (loss of skin color). This is the only skin-tone-specific note regarding safety monitoring.


Q: Can Azclear be used on body acne (back, chest)?

A: Regulatory guidance specifies applying the medication topically and directly to the affected skin area(s). The product labeling does not explicitly restrict the application site to the face, indicating it can be used on any affected skin area.


Q: Are there restrictions on using other topical exfoliating ingredients with Azclear?

A: Official regulatory documents restrict co-administration with other topical products that cause additive skin irritation. This restriction includes products such as peeling agents or abrasive cleansers.


Q: Is the Azclear active ingredient derived from natural sources?

A: The active ingredient, azelaic acid, is a dicarboxylic acid that naturally occurs in grains such as wheat and barley. However, it is typically produced synthetically for use in pharmaceutical products.


Q: How does the TGA (or FDA/EMA) classify Azclear?

A: Azelaic acid is classified by regulatory bodies as a topical pharmaceutical product. It belongs to the pharmacological class of a Topical Antiacne Agent and is clinically recognized to function concurrently as a Keratolytic Agent.


Q: What are the common ingredients Azclear is contraindicated with, besides the active ingredient?

A: Use of the medication is officially contraindicated for any individual with a known hypersensitivity to the active ingredient (azelaic acid) or any other ingredient in the specific formulation. This means caution is required regarding all non-active components.

How should Azclear be stored and disposed of?

How to Store and Dispose of Azclear

Official labeling defines specific conditions for storing Azelaic Acid Cream to maintain its stability. The product must be stored within a restricted temperature range, typically 15 C to 30 C (59 F to 86 F), and must be strictly protected from freezing. To preserve container integrity, the product should be kept in a cool, dry place with the lid tightly closed.

All medication, including Azclear, must be stored out of the sight and reach of children.

Disposal Requirements

Unused or expired cream should be disposed of following official guidelines. The preferred method is using a drug take-back program. If a program is unavailable, household disposal should involve mixing the medicine with an undesirable substance, sealing it in a container, and placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azclear found in:

A-Z Index: